Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms

Venous thromboembolism in cancer patients: a population-based cohort study

(2020) F. I. Mulder et al.   BLOOD

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms

(2018) Malin Hultcrantz et al.   ANNALS OF INTERNAL MEDICINE

High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation

(2018) Kai Wille et al.   ANNALS OF HEMATOLOGY

Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis

(2016) Yu-Qing Pei et al.   ANNALS OF HEMATOLOGY

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

(2016) A. Kaifie et al.   Journal of Hematology & Oncology

Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study

(2015) Malin Hultcrantz et al.   JOURNAL OF CLINICAL ONCOLOGY

In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology

(2014) T. Barbui et al.   BLOOD

Splanchnic vein thrombosis in myeloproliferative neoplasms

(2013) Mallika Sekhar et al.   BRITISH JOURNAL OF HAEMATOLOGY

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

(2013) A Tefferi et al.   LEUKEMIA

Venous thromboembolism: Epidemiology and magnitude of the problem

(2012) Samuel Z. Goldhaber   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

(2012) T. Barbui et al.   BLOOD

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Splanchnic vein thrombosis: clinical presentation, risk factors and treatment

(2010) Valerio De Stefano et al.   Internal and Emergency Medicine

Thrombosis in primary myelofibrosis: incidence and risk factors

(2009) T. Barbui et al.   BLOOD

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA